Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation

Journal of Cellular Biochemistry

Volumn 101, Issue 5, 2007, Pages 1109-1124

  Baksh, Dolores ^a   Boland, Genevieve M ^a   Tuan, Rocky S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

LRP5; Mesenchymal stem cells; Osteogenesis; Wnt

Indexed keywords

FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; TRANSCRIPTION FACTOR 7; WNT PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOLECULAR INTERACTION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AGED; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; FRIZZLED RECEPTORS; GENES, REPORTER; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MESENCHYMAL STEM CELLS; MIDDLE AGED; MODELS, BIOLOGICAL; OSTEOCALCIN; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 34547925581     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21097     Document Type: Article

References (39)

1. Baksh D, Davies JE, Zandstra PW. 2003. Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp Hematol 31:723-732.
2. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J, Nusse R. 1996a. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382:225-230.
3. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J, Nusse R. 1996b. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382:225-230.
4. Boland GM, Perkins G, Hall DJ, Tuan RS. 2004. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93:1210-1230.
5. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
6. Bruder SP, Jaiswal N, Haynesworth SE. 1997. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294.
7. Cadigan KM, Nusse R. 1997. Wnt signaling: A common theme in animal development. Genes Dev 11:3286-3305.
8. Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res 9:641-650.
9. De Boer J, Siddappa R, Gaspar C, van Apeldoorn A, Fodde R, Van Blitterswijk C. 2004a. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34:818-826.
10. De Boer J, Wang HJ, Van Blitterswijk C. 2004b. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10:393-401.
11. Du SJ, Purcell SM, Christian JL, McGrew LL, Moon RT. 1995. Identification of distinct classes and functional domains of Wnts through expression of wild-type and chimeric proteins in Xenopus embryos. Mol Cell Biol 15: 2625-2634.
12. Etheridge SL, Spencer GJ, Heath DJ, Genever PG. 2004. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22:849-860.
13. Golan T, Yaniv A, Bafico A, Liu G, Gazit A. 2004. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. J Biol Chem 279:14879-14888.
14. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
15. Haleem-Smith H, Derfoul A, Okafor C, Tuli R, Olsen D, Hall DJ, Tuan RS. 2005. Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol 30:9-20.
16. He X, Semenov M, Tamai K, Zeng X. 2004. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: Arrows point the way. Development 131:1663-1677.
17. Kahler RA, Westendorf JJ. 2003. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 278:11937-11944.
18. Kahler RA, Galindo M, Lian J, Stein GS, van Wijnen AJ, Westendorf JJ. 2006. Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J Cell Biochem 97:969-983.
19. Katoh Y, Katoh M. 2006. WNT antagonist, SFRP1, is Hedgehog signaling target. Int J Mol Med 17:171-175.
20. Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT. 2000. The Wnt/Ca2+ pathway: A new vertebrate Wnt signaling pathway takes shape. Trends Genet 16:279-283.
21. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN. 2003. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4:349-360.
22. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML. 2002. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 11-19.
23. Liu G, Bafico A, Aaronson SA. 2005. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol Cell Biol 25:3475-3482.
24. Mikels AJ, Nusse R. 2006. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115.
25. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. 2004. WNT and beta-catenin signalling: Diseases and therapies. Nat Rev Genet 5:691-701.
26. Murdoch B, Chadwick K, Martin M, Shojaei F, Shah KV, Gallacher L, Moon RT, Bhatia M. 2003. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc Natl Acad Sci USA 100:3422-3427.
27. Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R. 2004. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: Novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 318:259-264.
28. Ohnaka K, Tanabe M, Kawate H, Nawata H, Takayanagi R. 2005. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun 329:177-181.
29. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
30. Polakis P. 2000. Wnt signaling and cancer. Genes Dev 14: 1837-1851.
31. Rulifson EJ, Wu CH, Nusse R. 2000. Pathway specificity by the bifunctional receptor frizzled is determined by affinity for wingless. Mol Cell 6:117-126.
32. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. 2004. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10:55-63.
33. Sheldahl LC, Park M, Malbon CC, Moon RT. 1999. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol 9: 695-698.
34. Tetsu O, McCormick F. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
35. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899-908.
36. Ueda Y, Hijikata M, Takagi S, Takada R, Takada S, Chiba T, Shimotohno K. 2002. Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts. Int J Cancer 99:681-688.
37. van Es JH, Barker N, Clevers H. 2003. You Wnt some, you lose some: Oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 13:28-33.
38. Veeman MT, Axelrod JD, Moon RT. 2003. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5:367-377.
39. Yang-Snyder J, Miller JR, Brown JD, Lai CJ, Moon RT. 1996. A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol 6:1302-1306.